3.60
price down icon1.37%   -0.05
after-market Dopo l'orario di chiusura: 3.60
loading

Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
5.90%
41.34
39.04 39.03 37.20 46.92
Depreciation and Amortization
0.00%
0.104
0.104 0.104 0.104 0.104
Operating Income/Loss
5.90%
-41.34
-39.04 -39.03 -37.20 -46.92
Income/Loss From Continuing Operations Before Tax
8.47%
-36.95
-34.07 -33.32 -30.93 -40.28
Income Tax Expense/Benefit
1.97%
0.207
0.203 0.225 0.226 0.243
Income/Loss From Continuing Operations After Tax
8.43%
-37.16
-34.27 -33.54 -31.15 -40.52
Net Income/Loss
8.43%
-37.16
-34.27 -33.54 -31.15 -40.52
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.66%
83.75
85.16 0.0666 84.42 84.25
Diluted Average Shares
1.66%
83.75
85.16 0.0666 84.42 84.25
Basic Earnings Per Share
10.00%
-0.44
-0.40 -0.40 -0.37 -0.48
Diluted Earnings Per Share
10.00%
-0.44
-0.40 -0.40 -0.37 -0.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):